Selected article for: "infected population and observed infected population"

Author: Cohen, Adam L.; Sahr, Philip K.; Treurnicht, Florette; Walaza, Sibongile; Groome, Michelle J.; Kahn, Kathleen; Dawood, Halima; Variava, Ebrahim; Tempia, Stefano; Pretorius, Marthi; Moyes, Jocelyn; Olorunju, Steven A. S.; Malope-Kgokong, Babatyi; Kuonza, Lazarus; Wolter, Nicole; von Gottberg, Anne; Madhi, Shabir A.; Venter, Marietjie; Cohen, Cheryl
Title: Parainfluenza Virus Infection Among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Children and Adults Hospitalized for Severe Acute Respiratory Illness in South Africa, 2009–2014
  • Document date: 2015_9_19
  • ID: kc85pev4_30
    Snippet: In conclusion, based on 6 years of respiratory disease surveillance, PIV is a common cause of SARI among children <5 years in South Africa. Among children, the observed incidence of PIV is higher in the HIV-infected population than the HIVuninfected population. A vaccine to protect against PIV is not currently available, but vaccine candidates are in the clinical testing phase [30] . The findings of our study accentuate the need to target childre.....
    Document: In conclusion, based on 6 years of respiratory disease surveillance, PIV is a common cause of SARI among children <5 years in South Africa. Among children, the observed incidence of PIV is higher in the HIV-infected population than the HIVuninfected population. A vaccine to protect against PIV is not currently available, but vaccine candidates are in the clinical testing phase [30] . The findings of our study accentuate the need to target children for PIV prevention strategies including vaccination, should a vaccine against PIV become available.

    Search related documents:
    Co phrase search for related documents
    • common cause and disease surveillance: 1
    • common cause and observed incidence: 1, 2, 3, 4
    • common cause and PIV observed incidence: 1, 2
    • common cause and study finding: 1
    • common cause and vaccination include: 1
    • disease surveillance and observed incidence: 1, 2, 3, 4, 5, 6
    • disease surveillance and respiratory disease surveillance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease surveillance and testing phase: 1, 2
    • disease surveillance and vaccination include: 1, 2, 3
    • observed incidence and PIV observed incidence: 1, 2, 3, 4
    • observed incidence and study finding: 1
    • observed incidence and testing phase: 1, 2